• Home
  • Metro Asian News
  • Misc Asia
  • Lifestyle
  • Business
  • Art
  • Health
  • Eat Out
  • Events
  • Podcasts
ABOUT
Advertise in GAT
Contact us
Monday, May 29, 2023
Georgia Asian Times
International Insurance of Georgia
  • Home
  • Metro Asian News
  • Misc Asia
  • Lifestyle
  • Business
  • Art
  • Health
  • Eat Out
  • Events
  • Podcasts
  • Login
No Result
View All Result
  • Home
  • Metro Asian News
  • Misc Asia
  • Lifestyle
  • Business
  • Art
  • Health
  • Eat Out
  • Events
  • Podcasts
No Result
View All Result
Georgia Asian Times
No Result
View All Result
  • Home
  • Metro Asian News
  • Misc Asia
  • Lifestyle
  • Business
  • Art
  • Health
  • Eat Out
  • Events
  • Podcasts
Home Headline

Philip Morris sees six million U.S. smokers switching to iQOS device if cleared

Georgia Asian Times by Georgia Asian Times
January 25, 2018
in Headline, Health

A man uses a Philip Morris iQOS e-cigarette in Tokyo, Japan May 12, 2017. REUTERS/Issei Kato/Files

Share on FacebookShare on Twitter

Washington DC, January 25, 2018 – Philip Morris International Inc told a U.S. advisory panel on Wednesday that it expects around 6 million smokers to switch completely to its iQOS electronic tobacco device if the company is allowed to claim it is less risky than cigarettes.

A man uses a Philip Morris iQOS e-cigarette in Tokyo, Japan May 12, 2017. REUTERS/Issei Kato/Files

The sleek, penlike iQOS device heats tobacco but does not burn it. The company hopes to convince the U.S. Food and Drug Administration advisory panel that the product contains fewer harmful chemicals than cigarettes and reduces the risk of smoking-related diseases for smokers who switch.

The panel will discuss the company’s application for two days and on Thursday will vote on whether the company’s data supports one of three potential “modified risk” claims that would be used on the product’s label and in marketing.

The vote is not binding but will influence the FDA’s decision.

AD: High Museum of Atlanta AD: High Museum of Atlanta

Electronic cigarettes currently on the market use a nicotine-laced liquid. Most toxic chemicals in cigarette smoke are produced when tobacco combusts.

IQOS is used by nearly 4 million people in 30 markets outside the United States but needs FDA authorization to be marketed in America.

Philip Morris says iQOS produces up to 95 percent fewer potentially harmful chemicals than regular cigarettes. The company said if 15 percent of U.S. daily smokers switched completely to iQOS it would translate to about 6 million smokers over seven to 10 years. The figure does not include smokers who might use iQOS in addition to cigarettes.

Moira Gilchrist, Philip Morris’ vice president of scientific and public communications, estimated that 90,000 smoking-related deaths could have been averted over 20 years based on an assumed switch rate of 15 percent.

The panel’s discussion comes amid an intense debate over the potential risks and benefits associated with e-cigarettes. On Tuesday, the National Academies of Sciences, Engineering and Medicine, summarizing data from hundreds of scientific studies, said e-cigarettes are safer than cigarettes and help smokers quit. But the report also found “substantial evidence” that youths who use e-cigarettes are more likely to try traditional cigarettes.

FDA staff in a preliminary review of Philip Morris’ application said that iQOS contains fewer harmful chemicals than cigarettes but that it was unclear whether reduced exposure translates into reduced risk of disease.

Results of a study in mice that could shed additional light on additional cancer risk are expected in June.

The advisory panel will recommend whether the company should be allowed to claim that iQOS “can reduce the risks of tobacco-related diseases” or that it “presents less risk of harm than continuing to smoke cigarettes.”

A third, easier-to-prove claim would state that iQOS “significantly reduces your body’s exposure to harmful or potentially harmful chemicals.”

The FDA is expected to decide whether Philip Morris can sell iQOS within the next few months. It will decide separately whether to authorize the modified-risk claims. If cleared, iQOS would be sold in the United States by Philip Morris’ partner Altria Group Inc. – Reuters

Previous Post

ASEAN-focused China fund raising up to $3 billion for Silk Road projects: sources

Next Post

At Davos, delegates talk down Trump but bet big on America

Georgia Asian Times

Georgia Asian Times

Related Posts

Loneliness poses risks as deadly as smoking says Surgeon General
Health

Loneliness poses risks as deadly as smoking says Surgeon General

May 2, 2023
Joon Sup Lee selected to head Emory Healthcare as CEO
Health

Joon Sup Lee selected to head Emory Healthcare as CEO

May 2, 2023
Health

What to know about new research on coffee and heart risks

March 22, 2023
Celebs tout ice baths, but science on benefits is lukewarm
Health

Celebs tout ice baths, but science on benefits is lukewarm

February 10, 2023
Health

DHS Receives Approval to Renew Simplified Process for Seniors Applying for SNAP

January 26, 2023
You’ll likely be happier if your home follows the ‘3-30-300 rule’
Health

You’ll likely be happier if your home follows the ‘3-30-300 rule’

December 22, 2022
Next Post

At Davos, delegates talk down Trump but bet big on America

Signup Free E-Newsletter

Upcoming Events

Jul 14
6:00 pm - 10:30 pm

GAT 25 Most Influential Asian Americans in Georgia 2023

View Calendar
Logo

 

CONTACT US

Follow Us

MOST INFLUENTIAL

2023 GAT 25 Most Influential Asian American Pacific Islanders in Georgia

2023 GAT 25 Most Influential Asian American Pacific Islanders in Georgia

April 30, 2023
GAT 25 Most Influential Asian Americans Gala celebrates Asian voice

GAT 25 Most Influential Asian Americans Gala celebrates Asian voice

July 18, 2022

Video highlights of GAT 25 Most Influential Asian Americans in Georgia

July 17, 2022

LINKS OF INTEREST

ATL Asian Film Festival

     

GAT AAPI SUMMIT 2023

  • Contact Us
  • Advertise in GAT
  • About
  • Privacy Policy
  • Terms of Use

© 2023 Georgia Asian Times - Empowered by 8SOL. Managed by Arckopolis.

No Result
View All Result
  • Home
  • Metro Asian News
  • Misc Asia
  • Lifestyle
  • Business
  • Art
  • Health
  • Eat Out
  • Events
  • Podcasts

© 2023 Georgia Asian Times - Empowered by 8SOL. Managed by Arckopolis.

Welcome Back!

Sign In with Google
OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Early Bird (May 19-31, 2023)

  • Honoree

    $225.00
    Select
  • Single Seat

    $225.00
    Select
  • Table of 8

    $1,800.00
    Select

Subscribe

Stay ahead of the curve with Georgia Asian Times’ exclusive newsletter. Get the hottest news stories and cultural insights delivered straight to your inbox. No subscription fees, just pure Asian excellence

 

    Loading
    Loading
    Loading
    Loading
    Loading
    Register for FREE to read the rest of this article, or log in to your account.

      Or Login Here :

      [loginfrm]

      Are you sure want to unlock this post?
      Unlock left : 0
      Are you sure want to cancel subscription?